Author

Hoi Ching Cheng

Observed name: Hoi C. Cheng

Observed institutions: Tuen Mun Hospital, Pamela Youde Nethersole Eastern Hospital, Queen Elizabeth Hospital

OpenAlex ID: A5112376743

Analysis of Plasma Epstein-Barr Virus DNA in Nasopharyngeal Cancer After Chemoradiation to Identify High-Risk Patients for Adjuvant Chemotherapy: A Randomized Controlled Trial

2018 · Anthony T.C. Chan, Edwin P. Hui, et al. · Journal of Clinical Oncology · 254

Whole-exome sequencing identifies MST1R as a genetic susceptibility gene in nasopharyngeal carcinoma

2016 · Wei Dai, Hong Zheng, et al. · Proceedings of the National Academy of Sciences · 88

Acalabrutinib Plus Bendamustine-Rituximab in Untreated Mantle Cell Lymphoma

2025 · Michael Wang, Michael Wang, et al. · Journal of Clinical Oncology · 67

A multicenter randomized controlled trial (RCT) of adjuvant chemotherapy (CT) in nasopharyngeal carcinoma (NPC) with residual plasma EBV DNA (EBV DNA) following primary radiotherapy (RT) or chemoradiation (CRT).

2017 · Anthony T. C. Chan, Edwin Pun Hui, et al. · Journal of Clinical Oncology · 21

Works count: 4

Citation count: 430

H-index: 4

I10-index: 4